[HTML][HTML] Interleukin-12 and Th1 immune response in Crohn's disease: Pathogenetic relevance and therapeutic inplication

I Peluso, F Pallone, G Monteleone - World Journal of Gastroenterology, 2006 - wjgnet.com
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the
gastrointestinal tract that share clinical and pathological characteristics. The most accredited …

[HTML][HTML] Interleukin-12 and Th1 immune response in Crohn's disease: Pathogenetic relevance and therapeutic inplication

I Peluso, F Pallone, G Monteleone - World journal of …, 2006 - ncbi.nlm.nih.gov
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the
gastrointestinal tract that share clinical and pathological characteristics. The most accredited …

After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

Z Zhang, DJ Hinrichs, H Lu, H Chen, W Zhong… - International …, 2007 - Elsevier
Inflammatory bowel disease (IBD), typified by Crohn's disease and ulcerative colitis, is a
common disorder characterized by recurrent and serious inflammation of the gastrointestinal …

[HTML][HTML] Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease

I Aggeletopoulou, SF Assimakopoulos… - World journal of …, 2018 - ncbi.nlm.nih.gov
Considering that both innate and adaptive immune responses are involved in the
pathogenesis of Crohn's disease (CD), novel therapeutic options have significantly been …

Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody

IJ Fuss, C Becker, Z Yang, C Groden… - Inflammatory bowel …, 2006 - academic.oup.com
Background Interleukin (IL)-12p70 and IL-23 are key T helper-1 (TH1) cytokines that drive
the inflammation seen in numerous models of intestinal inflammation. These molecules …

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

[HTML][HTML] Role of the IL-23/IL-17 axis in Crohn's disease

SI Siakavellas, G Bamias - Discovery medicine, 2012 - discoverymedicine.com
Crohn's disease is an immune-mediated disease that is characterized by chronic intestinal
inflammation. Effector CD4+ T-lymphocytes are expanded in Crohn's disease-associated …

IL-17/23, potential targets for Crohn's disease

I Wolowczuk, M Allez, M Chamaillard - Th 17 Cells: Role in Inflammation …, 2009 - Springer
Biological agents have profoundly changed the therapeutical management of Crohn's
disease and ulcerative colitis, the major clinical subentities of inflammatory bowel disease …

Targeting IL-23 in Crohn's disease

S Sedda, G Bevivino, G Monteleone - Expert Review of Clinical …, 2018 - Taylor & Francis
ABSTRACT Introduction: Interleukin (IL)-23, a cytokine produced by antigen presenting
cells, targets both T cells and non-T cell types with the downstream effect of enhancing …

Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention

GW Sewell, A Kaser - Journal of Crohn's and Colitis, 2022 - academic.oup.com
Abstract The interleukin-23 [IL-23] cytokine, derived predominantly from macrophages and
dendritic cells in response to microbial stimulation, has emerged as a critical promoter of …